Eli Lilly (LLY)
$915.01
13.21 (1.46%)
LLY Stock Quote Delayed 30 Minutes
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
3.03M
Day's Range
$896.60 - $922.43
52-Week Range
$711.40 - $972.53
Dividend & Yield
$5.20 (0.57%)
LLY Stock Predictions, Articles, and Eli Lilly News
3 Stocks With the Potential to Knock Tesla Out of the Magnificent 7
These stocks are best positioned to usurp Tesla's position within Magnificent 7 stocks as it slumps further in February.
My Top 3 Stock Candidates to Replace Tesla in the Magnificent 7
The Magnificent 7 stocks are mostly doing well in 2024. It would still be a good bet if not for Elon Musk’s company.
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
